Market analysis of chondroitin and glucosamine as dietary supplements

Chondroitin and glucosamine are widely used as dietary supplements for osteoarthritis (OA), despite inconsistent clinical evidence and limited regulatory oversight. Concerns remain regarding efficacy, bioavailability, safety and discrepancies between marketed claims and scientific data. To investigate the characteristics of marketed chondroitin and glucosamine dietary supplements and to evaluate the clinical evidence regarding their efficacy and safety in OA. This study combined a cross-sectional market analysis of 110 dietary supplements with a structured review of clinical studies. Supplements were analyzed with respect to composition, dosage, pricing, labelling and marketing strategies. A PubMed search was conducted to identify clinical trials and meta-analyses investigating orally administered chondroitin and/or glucosamine in OA patients. Eligible studies were analyzed descriptively due to heterogeneity. The product analysis revealed highly variable pricing, with substantial cost differences and no clear link between price and clinical effectiveness. Marketing strategies often relied on packaging and presentation to imply scientific validation, frequently without sufficient supporting evidence. The available clinical evidence does not provide a consistent or robust basis for confirming the efficacy of chondroitin and glucosamine in OA. The effectiveness of chondroitin and glucosamine in OA in treating OA is questionable, a major problem being the poor bioavailability. Overall, the field is plagued by poor scientific evidence.

Authors

Institutions

Publication Details

Journal
Naunyn-Schmiedeberg s Archives of Pharmacology
Published
2026-11-21
DOI
https://doi.org/10.1007/s00210-026-06085-z
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Market analysis of chondroitin and glucosamine as dietary supplements

Bastian Schirmer, Roland Seifert, Charlotte Peters
Naunyn-Schmiedeberg s Archives of Pharmacology
Osteoarthritis Treatment and Mechanisms
article

Market analysis of chondroitin and glucosamine as dietary supplements

Bastian Schirmer, Roland Seifert, Charlotte Peters
article en

Abstract

Chondroitin and glucosamine are widely used as dietary supplements for osteoarthritis (OA), despite inconsistent clinical evidence and limited regulatory oversight. Concerns remain regarding efficacy, bioavailability, safety and discrepancies between marketed claims and scientific data. To investigate the characteristics of marketed chondroitin and glucosamine dietary supplements and to evaluate the clinical evidence regarding their efficacy and safety in OA. This study combined a cross-sectional market analysis of 110 dietary supplements with a structured review of clinical studies. Supplements were analyzed with respect to composition, dosage, pricing, labelling and marketing strategies. A PubMed search was conducted to identify clinical trials and meta-analyses investigating orally administered chondroitin and/or glucosamine in OA patients. Eligible studies were analyzed descriptively due to heterogeneity. The product analysis revealed highly variable pricing, with substantial cost differences and no clear link between price and clinical effectiveness. Marketing strategies often relied on packaging and presentation to imply scientific validation, frequently without sufficient supporting evidence. The available clinical evidence does not provide a consistent or robust basis for confirming the efficacy of chondroitin and glucosamine in OA. The effectiveness of chondroitin and glucosamine in OA in treating OA is questionable, a major problem being the poor bioavailability. Overall, the field is plagued by poor scientific evidence.

Naunyn-Schmiedeberg s Archives of Pharmacology
Medizinische Hochschule Hannover (DE)
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Market analysis of chondroitin and glucosamine as dietary supplements — Bastian Schirmer, Roland Seifert, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology (2026) | TGRS Research Map | TGRS